Home > Press > Platypus Technologies awarded $600K federal grant
Abstract:
Platypus Technologies, LLC a life sciences nanotechnology company has been awarded a Phase I Small Business Innovation Research (SBIR) grant for $600,000 from the National Institute of Allergy and Infectious Diseases. The funds will be used to develop hepatitis screening assays that can simultaneously detect multiple proteins from a single sample. The assays will utilize the Company's proprietary liquid crystal-based technology for rapid detection of molecular interactions. Platypus Technologies has received over $15.5 million in federal funding to develop nanotechnology products for the physical and life sciences.
####
About Platypus Technologies, LLC
Platypus Technologies, LLC develops innovative products for the analytic and life sciences based upon the application of nanotechnologies. Utilizing recent advances in nanoscale and material science, the company provides advanced tools for use in proteomics, cell-based studies, and environmental monitoring. The company is developing a range of products that derive from a proprietary platform technology utilizing liquid crystals for the rapid detection of molecular interactions. In August 2007, the Company launched its Oris™ Cell Migration Assay. Platypus has 21 employees and is located in the Fitchburg Technology Campus.
For more information, please click here
Contacts:
Platypus Technologies, LLC
5520 Nobel Drive, Suite 100
Madison, WI 53711
Minnie Gupta, Director of Marketing
608-237-1270
Copyright © Platypus Technologies, LLC
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Atomic force microscopy in 3D July 5th, 2024
Aston University researcher receives £1 million grant to revolutionize miniature optical devices May 17th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||